calliditas therapeutics (CALT.US) will release its financial report on November 11th.

$Calliditas Therapeutics (CALT.US)$ will release its financial report on November 11th, investors are welcome to pay attention. How was the previous performance? $Calliditas Therapeutics (CALT.US)$ revenue in 2024/Q2 was 0.55978 billion Swedish Krona, net income was -47.478 million Swedish Krona, and EPS was -1.76 Swedish Krona. Revenue in 2023/Q3 was 0.294592 billion Swedish Krona, net income was -0.168357 billion Swedish Krona, and EPS was -6.28 Swedish Krona. The above data

Futu NewsNov 6 09:00

DJ Symbol for Calliditas Therapeutics AB (CALTX-SK) Now 3407.TO

Dow JonesOct 15 05:08

Delisting of Calliditas Therapeutics AB (Publ) From Nasdaq Stockholm

PR NewswireSep 16 21:46

NephCure Announces First-Ever IgA Nephropathy (IgAN) Awareness Day on September 26, 2024

PR NewswireSep 3 20:00

Notice of Extraordinary Meeting of Calliditas Therapeutics AB (Publ)

PR NewswireSep 3 19:13

Following The Announcement By Asahi Kasei That It Controls Over 90% Of Calliditas Therapeutics Has Resolved To Apply For Delisting Its Common Shares From Nasdaq Stockholm And Its American Depositary Shares From The Nasdaq Global Select Market

BenzingaSep 3 18:42